NOVARTIS N - stock earnings
NOVN.SW Upcoming estimated earnings
Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
---|---|---|---|---|
June 2, 2024 BeforeMarket | - / 1.6800000000 | - | - / 11.4 billion | - |
NOVN.SW Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | 7.1 billion CHF | 9.9 billion CHF |
2023Q3 | 1.6 billion CHF | 11.1 billion CHF |
2023Q2 | 2.1 billion CHF | 12.5 billion CHF |
2023Q1 | 2.1 billion CHF | 12.1 billion CHF |
2022Q4 | 1.4 billion CHF | 12.1 billion CHF |
2022Q3 | 1.5 billion CHF | 12.5 billion CHF |
2022Q2 | 1.6 billion CHF | 12.5 billion CHF |
2022Q1 | 2.1 billion CHF | 11.9 billion CHF |
2021Q4 | 14.9 billion CHF | 12.3 billion CHF |
2021Q3 | 2.6 billion CHF | 12.5 billion CHF |
2021Q2 | 2.7 billion CHF | 12.3 billion CHF |
2021Q1 | 1.9 billion CHF | 12.0 billion CHF |
2020Q4 | 1.9 billion CHF | 11.7 billion CHF |
2020Q3 | 1.8 billion CHF | 11.5 billion CHF |
2020Q2 | 1.8 billion CHF | 11.0 billion CHF |
2020Q1 | 2.1 billion CHF | 12.2 billion CHF |
2019Q4 | 1.1 billion CHF | 12.3 billion CHF |
2019Q3 | 2.0 billion CHF | 12.4 billion CHF |
2019Q2 | 6.6 billion CHF | 11.7 billion CHF |
2019Q1 | 1.8 billion CHF | 11.4 billion CHF |
2018Q4 | 1.2 billion CHF | 13.4 billion CHF |
2018Q3 | 1.6 billion CHF | 11.1 billion CHF |
2018Q2 | 7.7 billion CHF | 13.4 billion CHF |
2018Q1 | 1.9 billion CHF | 12.4 billion CHF |
2017Q4 | 1.9 billion CHF | 12.9 billion CHF |
2017Q3 | 2.0 billion CHF | 12.3 billion CHF |
2017Q2 | 1.9 billion CHF | 11.9 billion CHF |
2017Q1 | 1.7 billion CHF | 11.8 billion CHF |
2016Q4 | 974.0 million CHF | 12.8 billion CHF |
2016Q3 | 1.9 billion CHF | 11.9 billion CHF |
2016Q2 | 1.8 billion CHF | 12.4 billion CHF |
2016Q1 | 1.9 billion CHF | 11.4 billion CHF |
2015Q4 | 1.0 billion CHF | 12.7 billion CHF |
2015Q3 | 1.8 billion CHF | 12.1 billion CHF |
2015Q2 | 1.7 billion CHF | 11.9 billion CHF |
2015Q1 | 12.6 billion CHF | 11.8 billion CHF |
2014Q4 | 1.5 billion CHF | 13.2 billion CHF |
2014Q3 | 3.1 billion CHF | 12.6 billion CHF |
2014Q2 | 2.3 billion CHF | 12.4 billion CHF |
2014Q1 | 2.6 billion CHF | 12.6 billion CHF |
2013Q4 | 1.8 billion CHF | 13.6 billion CHF |
2013Q3 | 2.0 billion CHF | 13.2 billion CHF |
2013Q2 | 2.4 billion CHF | 13.9 billion CHF |
2013Q1 | 2.3 billion CHF | 13.5 billion CHF |
2012Q4 | 1.9 billion CHF | 13.8 billion CHF |
2012Q3 | 2.3 billion CHF | 13.2 billion CHF |
2012Q2 | 2.6 billion CHF | 14.0 billion CHF |
2012Q1 | 2.1 billion CHF | 12.6 billion CHF |
2011Q4 | 1.1 billion CHF | 14.1 billion CHF |
2011Q3 | 2.2 billion CHF | 13.5 billion CHF |
2011Q2 | 2.3 billion CHF | 12.6 billion CHF |
2011Q1 | 2.5 billion CHF | 13.1 billion CHF |
2010Q4 | 2.0 billion CHF | 13.5 billion CHF |
2010Q3 | 2.2 billion CHF | 12.5 billion CHF |
2010Q2 | 2.6 billion CHF | 12.8 billion CHF |
2010Q1 | 3.1 billion CHF | 13.0 billion CHF |
2009Q4 | 2.4 billion CHF | 13.6 billion CHF |
2009Q3 | 2.2 billion CHF | 11.7 billion CHF |
2009Q2 | 2.2 billion CHF | 11.7 billion CHF |
2009Q1 | 2.2 billion CHF | 11.3 billion CHF |
2008Q4 | 1.6 billion CHF | 11.1 billion CHF |
2008Q3 | 2.3 billion CHF | 12.4 billion CHF |
2008Q2 | 2.3 billion CHF | 11.0 billion CHF |
2008Q1 | 2.3 billion CHF | 10.2 billion CHF |
2007Q4 | 1.0 billion CHF | 11.5 billion CHF |
2007Q3 | 8.0 billion CHF | 11.4 billion CHF |
2007Q2 | 2.5 billion CHF | 11.5 billion CHF |
2007Q1 | 2.6 billion CHF | 11.9 billion CHF |
2006Q4 | 2.0 billion CHF | 11.4 billion CHF |
2006Q3 | 2.3 billion CHF | 12.1 billion CHF |
2006Q2 | 2.1 billion CHF | 11.2 billion CHF |
2006Q1 | 2.5 billion CHF | 10.8 billion CHF |
2005Q4 | 1.8 billion CHF | 11.5 billion CHF |
2005Q3 | 2.1 billion CHF | 11.0 billion CHF |
2005Q2 | 2.1 billion CHF | 10.1 billion CHF |
2005Q1 | 1.8 billion CHF | 8.8 billion CHF |
2004Q4 | 1.6 billion CHF | 8.6 billion CHF |
2004Q3 | 1.9 billion CHF | 8.8 billion CHF |
2004Q2 | 1.9 billion CHF | 8.7 billion CHF |
2004Q1 | 1.6 billion CHF | 8.4 billion CHF |
2003Q4 | 1.7 billion CHF | 8.3 billion CHF |
2003Q3 | 1.7 billion CHF | 8.2 billion CHF |
2003Q2 | 1.8 billion CHF | 8.4 billion CHF |
2003Q1 | 1.4 billion CHF | 7.7 billion CHF |
2002Q4 | 2.3 billion CHF | 10.8 billion CHF |
2002Q3 | 1.6 billion CHF | 7.5 billion CHF |
2002Q2 | 2.1 billion CHF | 8.3 billion CHF |
2002Q1 | 1.8 billion CHF | 8.2 billion CHF |
2001Q4 | 1.7 billion CHF | 8.6 billion CHF |
2001Q3 | 1.8 billion CHF | 9.0 billion CHF |
2001Q2 | 1.9 billion CHF | 7.7 billion CHF |
2001Q1 | 1.9 billion CHF | 7.7 billion CHF |
2000Q4 | 1.8 billion CHF | 9.7 billion CHF |
2000Q3 | 1.5 billion CHF | 8.5 billion CHF |
2000Q2 | 2.1 billion CHF | 9.5 billion CHF |
2000Q1 | 2.1 billion CHF | 9.5 billion CHF |
NOVN.SW Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 12.5 billion CHF | 39.2 billion CHF |
2022 | 6.4 billion CHF | 47.9 billion CHF |
2021 | 21.9 billion CHF | 48.2 billion CHF |
2020 | 7.3 billion CHF | 44.8 billion CHF |
2019 | 6.9 billion CHF | 47.2 billion CHF |
2018 | 12.4 billion CHF | 52.3 billion CHF |
2017 | 7.5 billion CHF | 49.1 billion CHF |
2016 | 6.8 billion CHF | 50.3 billion CHF |
2015 | 17.6 billion CHF | 49.8 billion CHF |
2014 | 10.1 billion CHF | 53.0 billion CHF |
2013 | 8.1 billion CHF | 52.2 billion CHF |
2012 | 8.7 billion CHF | 52.7 billion CHF |
2011 | 8.6 billion CHF | 55.8 billion CHF |
2010 | 9.2 billion CHF | 48.2 billion CHF |
2009 | 8.7 billion CHF | 46.6 billion CHF |
2008 | 8.8 billion CHF | 45.5 billion CHF |
2007 | 13.5 billion CHF | 44.1 billion CHF |
2006 | 8.7 billion CHF | 44.8 billion CHF |
2005 | 8.1 billion CHF | 42.8 billion CHF |
2004 | 6.6 billion CHF | 32.1 billion CHF |
2003 | 6.2 billion CHF | 30.8 billion CHF |
2002 | 7.2 billion CHF | 32.1 billion CHF |
2001 | 7.1 billion CHF | 32.5 billion CHF |
2000 | 7.1 billion CHF | 35.5 billion CHF |
1999 | 6.7 billion CHF | 32.6 billion CHF |
1998 | 3.9 billion CHF | 20.4 billion CHF |
NOVN.SW
Price: CHF89.04
Dividend Yield: 0.05%
Forward Dividend Yield: 3.75%
Payout Ratio: 88.00%
Dividend Per Share: 3.30 CHF
Earnings Per Share: 3.75 CHF
P/E Ratio: 24.52
Exchange: EBS
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 3.9 million
Market Capitalization: 176.0 billion
Average Dividend Frequency: 1
Years Paying Dividends: 28
DGR3: 2.67%
DGR5: 2.63%
DGR10: 3.24%
DGR20: 5.75%